Australia's most trusted
source of pharma news
Thursday, 21 November 2024
Posted 20 November 2024 AM
Spray-on Skin is set to return across Australia, with Avita off-loading local commercialisation to a specialist medical distribution company.
Avita has signed an exclusive distribution agreement with Revolution Surgical, which sells a range of medical devices in Australia and New Zealand. The agreement covers the ReCell product platform for the two countries, as well as ReCell Go, pending regulatory approval.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.